Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › El Segundo › NPI 1225632029
Lab

Onsite Laboratories, LLC

Onsite Laboratories, LLC was paid $804K by Medicaid between Jan 2021 and Jul 2023, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

33Billing provider infoONSITE LABORATORIES, LLC
EL SEGUNDO, CA 90245
33aNPI1225632029assigned 11/23/2020
28Total paid$804K
24GClaims29,447
24DCodes billed4
24AFirst – last monthJan 2021 – Jul 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#203 of 561
Median peer was paid$222K
This provider vs. median3.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20218,999$226K
202220,300$575K
2023148$3K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 71% 10,509 4,643 $573K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 21% 13,326 4,703 $172K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 7.0% 5,494 2,667 $57K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 118 66 $3K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDERHEIM, ABIGAIL (OWNER AND CEO)